Biotech

All Articles

Novo inks $600M NanoVation deal to analyze genetic medicines ex-liver

.Novo Nordisk is proceeding its own push right into hereditary medicines, consenting to compensate N...

Innovent links cytokine to intestines cancer cells responses

.Innovent Biologics has created the case that its own checkpoint inhibitor-cytokine combination heal...

Merck, Daiichi ADC attacks goal in stage 3 bronchi cancer cells study

.A period 3 test of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate...

Rakovina deepens artificial intelligence focus along with collab to select cancer cells targets

.Five months after Rakovina Therapies turned towards expert system, the cancer-focused biotech has a...

Ascendis' dwarfism medication favorites in phase 3, threatens BioMarin

.Ascendis Pharma has actually become a potential danger to BioMarin's Voxzogo, disclosing stage 3 de...

Despite ph. 3 overlook, Alkeus views pathway ahead of time for eye health condition property

.Though Alkeus Pharmaceuticals' oral eye health condition resource fell short to substantially lower...

Kairos goes social with $6M IPO to fund tests of cancer drug

.With a triad of biotechs attacking the Nasdaq on Friday, it was easy to miss a smaller-scale social...

Vaccine and also Keytruda combo reliable in squamous tissue cancer

.Immune system checkpoint inhibitors are the superheroes of cancer cells therapy. Medications like B...

Cue Biopharma queues up J&ampJ vet as CBO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of substantial management hirings, shootings and...

Regeneron's Opdualag rival shows 57% response price

.Regeneron is actually back with lasting follow-up for its LAG-3 inhibitor and also PD-1 inhibitor c...